Your session is about to expire
← Back to Search
Digital Screening Tool for Tobacco Cessation (CanCEASE Trial)
N/A
Waitlist Available
Led By Olivier Drouin, MD, MSc MPH
Research Sponsored by St. Justine's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Parents or legal guardians of children 0-17 years old who smoke or use nicotine vaping products
Adolescent patients aged 14-17 years who smoke or use nicotine vaping products
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months of study follow up
Awards & highlights
CanCEASE Trial Summary
This trial will study an intervention to help parents and teens quit smoking/vaping, preventing 48,000 preventable deaths and $16.2 billion in health costs annually. It will assess feasibility and effectiveness to inform a larger trial.
Who is the study for?
This trial is for parents or guardians of children aged 0-17 who smoke or vape, and adolescents aged 14-17 who do the same. Participants must have used tobacco or a vaping product within the past week, be attending a scheduled medical appointment, and speak French or English well enough to complete questionnaires.Check my eligibility
What is being tested?
The CEASE program aims to help parents quit smoking by providing nicotine dependence treatment during their child's pediatric visits. For teens, the CEASE-A program offers similar support. The study will compare these programs against usual care in a pilot randomized controlled trial (RCT) to plan for a larger future RCT.See study design
What are the potential side effects?
Since this trial involves behavioral interventions rather than medications, traditional side effects are not expected. However, participants may experience stress or discomfort when attempting to quit smoking or vaping with the provided cessation support.
CanCEASE Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am a parent or guardian of a child who uses nicotine products.
Select...
I am between 14 and 17 years old and I use nicotine products.
CanCEASE Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months of study follow up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months of study follow up
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Abstinence at 6 months
Cotinine-confirmed quit
Feasibility of the intervention
+3 moreSecondary outcome measures
Proportion of participant reporting quit attempts at 1-, 3- and 6- months
Proportion of participants reporting intent to quit smoking/vaping
CanCEASE Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: CEASE Intervention armExperimental Treatment1 Intervention
The CEASE and CEASE-A interventions are tobacco and vaping cessation interventions delivered in pediatric practices, leveraging existing healthcare and community resources. They integrate evidence-based tobacco use screening and cessation assistance into routine visits to pediatric clinics. CEASE and CEASE-A are based on the 5A's model of smoking cessation: Ask about smoking, Advise to quit, Assess readiness to quit, Assist with a quit plan and Arrange follow-up. Given that CEASE and CEASE-A are one-time interventions, "Arrange" is removed, and the fourth step "Assist" is divided into two parts: a) providing phone/text/app quit support and b) providing NRT.
CEASE-A follows the same format at CEASE, but is modified slightly to address smoking and vaping in the adolescent target population
Group II: Control: Usual care conditionActive Control1 Intervention
The control condition will be care as is usually delivered in participating clinics with the possibility of receiving direct linkage with cessation services delivered via CEASE/CEASE-A at the end of the 6-month study period. Current practice does not include routine provision of assistance for parental/adolescent smoking or e-cigarette cessation (e.g., referral to quitlines, NRT prescription).
Find a Location
Who is running the clinical trial?
St. Justine's HospitalLead Sponsor
196 Previous Clinical Trials
78,899 Total Patients Enrolled
Olivier Drouin, MD, MSc MPHPrincipal InvestigatorCHU Sainte-Justine Research Centre
1 Previous Clinical Trials
300 Total Patients Enrolled
Nicholas Chadi, MD, MPHPrincipal InvestigatorCHU Sainte-Justine Research Centre
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am a parent or guardian of a child who uses nicotine products.I am a parent over 18, attending a medical appointment, and speak French or English well.I am over 18, my child is 17 or younger, we have a medical appointment, and I can read and answer in English or French.I am between 14-17 years old, speak English or French, and have agreed to participate.Have you used an e-cigarette or vaping device with nicotine in the past week, even if it was just one puff?I am 14-17 years old, meet the required criteria, and have consented to participate.Have you smoked any amount of cigarettes in the past week, even a single puff?I am 14-17 years old and use cigarettes or vape products.I am between 14 and 17 years old and I use nicotine products.
Research Study Groups:
This trial has the following groups:- Group 1: CEASE Intervention arm
- Group 2: Control: Usual care condition
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does this investigation still accept participants?
"Affirmative. Clinicaltrials.gov provides proof that this medical trial, which first went live on February 22nd 2023, is still open to patient recruitment. The study needs approximately 80 participants from a single clinical site."
Answered by AI
How many individuals are currently enrolled in this research endeavor?
"Affirmative. According to clinicaltrials.gov, the study posted on February 22nd 2023 is currently recruiting patients. 80 individuals from a single location are necessary for completion of this trial."
Answered by AI
What goals is this medical experiment looking to achieve?
"This medical trial will monitor the efficacy of its intervention over a period of 12 months, with primary outcome being Feasibility. Secondary outcomes include Quit attempts at 1-, 3- and 6- month intervals, Proportion of participants announcing intent to quit smoking/vaping during recruitment and follow up visits, as well as Proportion of participants that have made quit attempts in the same time frames."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger